EXSCIENTIA
Exscientia plc (Nasdaq: EXAI) today announced that David Hallett, interim Chief Executive Officer and Chief Scientific Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 at 7:00 a.m. EDT (12:00 p.m. BST).
A live webcast of the fireside chat will be available on the Company’s website, under the “Investors & Media” section at investors.exscientia.ai. An archived replay of the webcast will be available for approximately 30 days following the presentation.
About Exscientia
Exscientia is a technology-driven drug design and development company, committed to creating more effective medicines for patients, faster. Exscientia combines precision design with integrated experimentation, aiming to invent and develop the best possible drugs in the most efficient manner. Operating at the interfaces of human ingenuity, artificial intelligence (AI), automation and physical engineering, we pioneered the use of AI in drug discovery as the first company to progress AI-designed small molecules into a clinical setting. We have developed an internal pipeline focused on oncology, while our partnered pipeline extends to many other therapeutic areas. By leading this new approach to drug creation, we believe we can change the underlying economics of drug discovery and rapidly advance the best scientific ideas into medicines for patients.
For more information visit us on www.exscientia.com or follow us on LinkedIn @ex-scientia and X @exscientiaAI.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828867760/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Software Recognized as a Major Player in the IDC MarketScape: Asia/Pacific SAP Implementation Services 2024 Vendor Assessment10.9.2024 08:27:00 CEST | Press release
FPT Software has been named a Major Player in the IDC MarketScape: Asia/Pacific SAP Implementation Services 2024 Vendor Assessment (Doc # AP51467624, August 2024). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909631391/en/ (Graphic: Business Wire) This regional IDC MarketScape report evaluates 18 service providers across Asia Pacific in the SAP implementation services sector. The assessment, based on a comprehensive framework, analyzes each vendor's SAP implementation offerings, their adoption of SAP solutions, and the effectiveness of their respective growth strategies. As one of only three companies in Southeast Asia to become a Regional Strategic Services Partner for SAP in Asia Pacific and Japan, FPT Software has leveraged its access to SAP's regional expertise and market insights to deliver enhanced SAP S/4HANA Cloud migration and managed services. Supported by a global team of highly certified consultants, with ov
FPT Software and Vilja Join Forces to Advance Digital Banking10.9.2024 08:21:00 CEST | Press release
Global IT company FPT Software recently announced a strategic partnership with Nordic-leading core banking service provider, Vilja. As a global technology partner to Vilja, FPT Software aims to fortify its financial services portfolio to deliver more innovative digital banking solutions to customers worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909234829/en/ The signing ceremony took place at the Vietnam-Sweden Economic Forum in Stockholm, Sweden. (Photo: Business Wire) Leveraging FPT Software's extensive technical expertise and global reach, this partnership will introduce Vilja’s cloud-native, application programming interface (API)-first banking platform to global enterprises, with an initial focus on Asia's rapidly growing digital economy. This collaboration also includes the establishment of an R&D center in Asia, dedicated to pioneering diverse innovations that cater to the evolving demands of digital ba
Regula Helps Austrian Municipalities Facilitate ID Verification and Processing10.9.2024 08:00:00 CEST | Press release
Municipal registration offices across Austria have integrated advanced document readers Regula 7024M to automate and secure identity verification processes. This initiative is part of the “Sicheres Meldeamt” (secure registration office) project, launched by the Federal Ministry of Internal Affairs of Austria. In Austria, the municipal registration office (Meldeamt) plays a crucial role in the administrative process for both citizens and residents. It's where individuals are required to register their place of residence, which is an essential part of living in Austria. However, its role extends beyond mere registration; it facilitates a smooth transition for individuals moving within or to Austria, granting them access to public services and contributing to orderly municipal management. The need for modernization Traditionally, the verification of identity documents in Austrian registration offices has been based predominantly on manual work, which requires a certain level of expertise,
4P-Pharma Welcomes Marina Vasiliou, Christian Bechon, and Alain Sainsot as Independent Members of Its Board10.9.2024 07:30:00 CEST | Press release
Marina Vasiliou, Biogen France President and Managing Director Christian Bechon, Senior Partner chez Isalys Augmented Management Alain Sainsot, GTP Bioways founder and President 4P-Pharma, a clinical-stage startup based in Lille that develops disease-modifying therapies for untreated serious diseases, is delighted to welcome Marina Vasiliou, Christian Bechon, and Alain Sainsot as independent and non-executive members to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909483462/en/ 4P-Pharma welcomes Marina Vasiliou, Christian Bechon and Alain Sainsot as independent members of its board (Photo: Business Wire) These novel additions will strengthen 4P-Pharma's goal to become a commercial-stage, fully integrated biopharma company covering the whole value chain from discovery to commercialization. Revital Rattenbach, CEO of 4P-Pharma, says: "We proudly welcome three exceptional leaders to our Board of Di
Patient Safety Movement Foundation Honors Ruth Ann Dorrill, Kimberly Cripe, Dr. Peter Lachman with Humanitarian Awards and Dr. Mike Durkin with Lifetime Achievement Award10.9.2024 06:40:00 CEST | Press release
Capping an eventful two days at the 11th Annual World Patient Safety, Science & Technology Summit, the Patient Safety Movement Foundation (PSMF) presented its prestigious Humanitarian Awards to visionaries and change agents in patient safety. The honorees were Ruth Ann Dorrill, Assistant Inspector General, Office of Evaluation and Inspections, Office of Inspector General; Kimberly Chavalas Cripe, the President and Chief Executive Officer at Children’s Hospital of Orange County; and Dr. Peter Lachman, Lead, Faculty Quality Improvement, Royal College of Physicians of Ireland. A special Lifetime Achievement Award was given to Dr. Mike Durkin, Chair of the PSMF’s Governance Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909880433/en/ 2024 Humanitarian Award recipients (left column, from top to bottom): Ruth Ann Dorrill, Assistant Inspector General, Office of Evaluation and Inspections, Office of Inspector General, with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom